BioSpace News Archive

The health world is often divided between powerfully precise synthetic Western drugs and ancient, often-inconsistent natural Eastern medicinal solutions.

LSPedia, a leading SaaS provider specializing in product traceability solutions for the pharmaceutical industry, has partnered with Altro Pharmaceuticals, enabling Altro customers to easily comply with the Drug Supply Chain Security Act (DSCSA) ahead of the FDA’s final deadline on November 27, 2023.

Justera Health Ltd. (CSE: VTAL) (OTCQB: SCRSF) (formerly ScreenPro Security Inc.) (“Justera” or the “Company”) is pleased to announce it has completed the acquisition of Juillet Wellness Centre (“Juillet Wellness”), a wellness center located in Burnaby, British Columbia, as of July 24, 2023.

Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device and digital health platform company focused on diabetes and prediabetes, announced today the completion and positive results of its feasibility study for its implantable continuous glucose monitor technology for patients with Type 1 and Type 2 insulin-dependent diabetes.

BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) (“BioMark”) an advanced stage liquid biopsy company with a focus on hard-to-detect and treat cancers issued a statement today commenting on the recent market activity.

Better Therapeutics, Inc today announced that it issued 2,023,583 shares of its common stock under its At-The-Market program at an average price per share of $1.19.

Intrommune Therapeutics, Inc. today announced they have achieved Last Patient Last Visit in the Phase 1 OMEGA Clinical Study for patients with peanut allergy.

Eli Lilly and Company (NYSE: LLY) will announce its second-quarter 2023 financial results on Tuesday, Aug. 8, 2023.

Golden Gift, a 501(c)(3) nonprofit organization in support of the therapeutic use of blood plasma from young donors in treating age-related conditions, has shared an early announcement of significantly beneficial clinical trial evidence for Fresh Frozen Plasma (yFFP) Treatments.

ASRC Federal Data Solutions was awarded the Research Data Management and Reporting Support Services contract with the NIH’s National Institute of Environmental Health Sciences Division of Translational Toxicology.